This webinar, originally shown to participants of the AIntibody challenge, provides the preliminary findings for the AIntibody Benchmarking Competition, which included 33 teams from AI biotechnology companies, large technology, large pharma/biotech, small and medium pharma/biotech, non-profit and academic entities.

This was also presented at PEGS—the Protein Engineering Summit—in Boston in May. The competition compares experimentally derived antibodies to over 500 antibodies derived using computational (AI) approaches. Full competition results will be announced in Nature Biotech later this year.

We appreciate your feedback! Please feel free to email us at AIntibody@iqvia.com.